Is asthma in children still increasing? 20-year prevalence trends in northern Sweden

Linnea Hedman1, Martin Andersson1, Anders Bjerg2

  • 1Department of Public Health and Clinical Medicine, The OLIN unit, Umeå University, Umeå, Sweden.

Insights

Asthma diagnoses in children doubled between 1996 and 2017, but asthma symptoms and severity remained stable. This suggests earlier and more frequent diagnoses for mild childhood asthma cases.

Area of Science:

  • Pediatric respiratory health
  • Epidemiology of childhood asthma

Background:

  • Investigating asthma prevalence and trends in 8-year-old children in Norrbotten, Sweden.
  • Examining associations between asthma diagnosis, symptoms, medication use, and severity over time.

Purpose of the Study:

  • To describe prevalence trends of asthma in children.
  • To analyze the association between asthma diagnosis and morbidity indicators.

Main Methods:

  • Utilized data from the Obstructive Lung Disease in Northern Sweden (OLIN) studies.
  • Conducted parental questionnaire surveys with pediatric cohorts in 1996, 2006, and 2017.
  • Included 3,430 (1996), 2,585 (2006), and 2,785 (2017) children aged 8 years.

Main Results:

  • Wheezing prevalence remained stable (approx. 10%) across the study years.
  • Physician-diagnosed asthma significantly increased from 5.7% to 12.2% (p < .001).
  • Asthma medication use also rose, yet asthma symptoms and severity decreased among diagnosed children.

Conclusions:

  • Physician-diagnosed asthma doubled without a corresponding increase in asthma morbidity.
  • Increased diagnoses may be attributed to earlier identification of mild asthma cases.
  • Stable wheezing prevalence contrasts with rising asthma diagnoses in this pediatric population.
Abstract

Related Concept Videos

Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.5K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
394
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
288
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K